News

Aveir VR has an increased projected battery life that can be up to two times longer than other commercially available leadless pacemakers when using the International Organization for Standardization (ISO) standard settings

Medtronic adds to its robust clinical program with long-term data demonstrating the continued blood pressure lowering effect of the Symplicity renal denervation procedure.

Heart images may help to predict the risk of sudden cardiac death in heart attack survivors, according to the largest analysis of cardiac magnetic resonance (CMR) data to date.

Screening for atrial fibrillation should be integrated into flu vaccination and cancer screening programs, according to a survey of GPs conducted by the AFFECT-EU project and presented at EHRA 2022, a scientific congress of the European...

The aim of genetic testing in patients with an inherited cardiac disease is to determine the cause. In some conditions this helps clinicians make a precise diagnosis, provides information about prognosis, and determines the treatment.

FEops announced that it received authorization from the U.S. FDA for FEops HEARTguide™ pre-operative planning of left atrial appendage occlusion (LAAo) with the Abbott’s Amplatzer™ Amulet™ and Boston Scientific’s Watchman FLX™ device.

Treatment with mavacamten showed sustained improvement in left ventricular outflow tract (LVOT) gradients, New York Heart Association (NYHA) Class and N-terminal pro brain natriuretic peptide (NT-proBNP) levels At 48 and 84 Weeks,...

More patients receive the right medication when physicians receive health record system alerts

New clinical research presented at ACC.22 shows that the Zio service is a viable solution for the early detection of silent atrial fibrillation.

Recommendations on the prevention and management of interference caused by medical procedures in patients with implanted electronic cardiac devices is published today in EP Europace.